Advancing Medicines and Vaccines Production


image
image
image
image
image
image
image
image

nCovid-19 Update

Daktari Biotechnology approach to addressing the nCovid-19 pandemic is currently focused on developing a subunit spike protein or VLP vaccine, an interferon-based prophylactic and a small molecule compound.

Learn More
image image

Biosimilars Update

Daktari Biotechnology is applying bacmam expression technology to develop insulin, interferon and erythropoietin biosimilars products for managing and treating health needs related to cancer, diabetes etc.

Learn More
image image
image
About Us

We Innovate & Research to Give You Solutions

The novel Coronavirus SARS-CoV-2, which causes the respiratory illness called COVID-19, is the recent World pandemic to be declared by the World Health Organization. Through education, research, development and production in Kenya; we shall produce the medicines and vaccines to give Kenya and African solutions through:

  • Cancer
  • Cell & Molecular Biology
  • Chemistry
  • Microbiology
  • Virology
  • Infectious diseases
  • Neurology
  • Pharmacology
  • Toxicology
  • Animal Health
image
image
Technology

Technology & Advancements

We continue to improve on our technology every day as we advance medicine and vaccine development and production. Our pharmaceutical production will initially focus on producing Biosimilar biologics and small molecule generics using our latest technologies that include: Bacmam Expression System, BEVs Technology and long-lasting controlled release medicines for small molecules.

image
image
image
Products

Addressing Health Needs

Learn More

Coronavirus

We will produce SARS – Cov2 Vaccine Spike Protein subunit or Bacmam Psuedo Virus Particles using the Bacmam Expression System that combines baculovirus and human cell lines to expression.

Learn More

Diabetes

By producing insulin as a biosimilar we shall ensure that the growing number of people with diabetes in Kenya and in Africa live a productive uninterrupted life by managing the disease effectively.

Learn More

Cancer

Antibody based Immunotherapy, VEGF, erythropoietin and interferon biosimilars will be developed to manage and treat cancer alongside chemotherapy agents.

Learn More

Malaria

Long acting targeted agents will be extended to malaria to provide a paradigm shift in the management of malaria infections and hopefully other protozoa parasites in resource limited settings in Kenya and Africa.

Learn More

HIV & Hepatitis-B

Our expertise and abilities will transform anti-HIV and anti-Hepatitis-B medicines into effective long acting viral therapeutic.

Learn More

Diaspora University

Through the education plan set in the University, we shall have progressive research that improves on products and innovates new products.

Learn More

We'll ensure you always get the best results

You have the right to the highest attainable standard of health every day. Ours is to ensure you have this right everyday through available and affordable medicines and vaccines.

Contact Us